Amber

Pharma and biotech companies spend billions of dollars each year to acquire genomic data. Scientists need large genomic datasets to identify causes of disease and develop cures. However, growth of the genomic data market is hindered by small data quantities, data fragmentation, lack of data standardization and slow data acquisition.
Nebula Genomics will leverage blockchain technology to eliminate the middleman and empower people to own their personal genomic data. This will effectively lower sequencing costs and enhance data privacy, resulting in growth of genomic data. Our open protocol will leverage the genomic data growth by enabling data buyers to efficiently aggregate standardized data from many individuals and genomic databanks.

Click to see more

ICO’s Details

  • GENERAL INFORMATION
  • Pre-ICO Opening Date:

    To be announced

  • Pre-ICO Closing Date:

    To be announced

  • ICO Opening Date:

    To be announced

  • ICO Closing Date:

    To be announced

  • Country of Origin:

    USA

  • TOKEN DETAILS
  • Blockchain Type:

    Ethereum

  • Platform:

    ERC20

Team

George Church - Co-founder
Dennis Grishin - Co-founder
Kamal Obbad - Co-founder
Armon Rahim - Growth Lead
Kevin Quinn - Engineer

Advisors

Mirza Cifric
Preston Estep
Yining Zhao
Drew Volpe
Joe Urgo
D. A. Wallach

Disclosure: This page is created to provide market intelligence. This is not investment advice and does not constitute any solicitation or endorsement of any investment. Any investment you make is done at your own risk and at your full and absolute discretion.

Initial Offering News
EarnBet